ArticleBMC microbiology2025
Investigating the potential antibacterial, anti-biofilm, wound healing and anti-inflammatory activity of the extract of Aspergillus niger endophyte isolated from cucumber leaves: in vitro and in vivo study.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Untapped microbial factories for next-generation therapeutics: Endophytic fungi of medicinal plants.Microbial cell factories · 2026Review
- Secondary Metabolites from Diaporthe eres SK3, an Endophytic Fungus of Sellaginella kraussiana Sw. Collected from the Northeast Indian Hills, Exhibits Potential in Vitro Bioactivities.Current microbiology · 2026Article
- Endophytic Fungi as a Promising Source of Bioactive Compounds for Wound Healing: A Systematic Review.Microorganisms · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndophytic fungi are a vast inventory of bioactive compounds, offering potent, cost-effective, renewable, and low-toxicity alternatives for therapeutic applications. The current investigation focused on the endophytic fungus Aspergillus niger, which was isolated for the first time from Cucumis sativus (cucumber) leaves and subjected to comprehensive evaluation, including anti-inflammatory, antibacterial, anti-biofilm, and in vitro wound healing potential. 18 S rRNA gene sequencing was utilized to identify A. niger after isolation, and the fungus was cultivated on Asian rice to produce fungal metabolites. The high-resolution liquid chromatography-mass spectrometry (LC-HRESI-MS/MS) was then used to elucidate its phytochemical profile.
resultsFingerprint compounds detected in the ethyl acetate of the endophyte A. niger (ANM) revealed 15 compounds that are mainly pyrones and quinones in nature, including citric acid, nigerasperone A, aspernigrin A, aspinonene, campyrone B, aurasperone F, and plastoquinone-3. The ANM showed a strong antibacterial activity against S. aureus clinical isolates (MIC values ranging from 32 to 512 µg/mL) and a significant reduction in biofilm formation, where the total number of biofilm producers, S. aureus isolates, decreased from 19 to 6 after treatment with ½ MIC of ANM. Furthermore, ANM-treated WI38 human fibroblast cells displayed a wound closure percentage of 99.68% ± 0.02 compared to 83.37% ± 0.05 for the control cells. Additionally, the ANM demonstrated potential in promoting wound healing, particularly in infected wounds, through its antimicrobial, anti-inflammatory, and tissue-regenerating properties.
conclusionsThese findings highlight A. niger as a valuable source of natural therapeutics. Additional research is needed to explore its key active components and potential side effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.